Cargando…
AMPK activation: a therapeutic target for type 2 diabetes?
Type 2 diabetes (T2D) is a metabolic disease characterized by insulin resistance, β-cell dysfunction, and elevated hepatic glucose output. Over 350 million people worldwide have T2D, and the International Diabetes Federation projects that this number will increase to nearly 600 million by 2035. Ther...
Autores principales: | Coughlan, Kimberly A, Valentine, Rudy J, Ruderman, Neil B, Saha, Asish K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075959/ https://www.ncbi.nlm.nih.gov/pubmed/25018645 http://dx.doi.org/10.2147/DMSO.S43731 |
Ejemplares similares
-
Nutrient Excess and AMPK Downregulation in Incubated Skeletal Muscle and Muscle of Glucose Infused Rats
por: Coughlan, Kimberly A., et al.
Publicado: (2015) -
Improved Insulin Sensitivity 3 Months After RYGB Surgery Is Associated With Increased Subcutaneous Adipose Tissue AMPK Activity and Decreased Oxidative Stress
por: Xu, X. Julia, et al.
Publicado: (2015) -
Downregulation of AMPK Accompanies Leucine- and Glucose-Induced Increases in Protein Synthesis and Insulin Resistance in Rat Skeletal Muscle
por: Saha, Asish K., et al.
Publicado: (2010) -
Activation of AMP-Activated Protein Kinase by Interleukin-6 in Rat Skeletal Muscle: Association With Changes in cAMP, Energy State, and Endogenous Fuel Mobilization
por: Kelly, Meghan, et al.
Publicado: (2009) -
AMPK Activity: A Primary Target for Diabetes Prevention with Therapeutic Phytochemicals
por: Chung, Min-Yu, et al.
Publicado: (2021)